Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 232 | 138 | 55 | 119 | 10 |
| Receivables | N/A | N/A | N/A | N/A | 20 |
| TOTAL | $458 | $168 | $130 | $223 | $179 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 191 | 52 | 0 | 0 | 0 |
| TOTAL | $191 | $52 | $N/A | $N/A | $N/A |
| Total Assets | $649 | $220 | $130 | $223 | $179 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,916 | 6,740 | 7,190 | 6,717 | 7,050 |
| Accrued Expenses | 2,600 | 2,465 | 2,328 | 2,190 | 2,053 |
| TOTAL | $11,941 | $11,394 | $11,100 | $10,094 | $9,327 |
| Non-Current Liabilities | |||||
| Long Term Debt | 122 | 122 | 122 | 122 | N/A |
| Deferred Revenues | 2,001 | 1,937 | 1,385 | 1,033 | N/A |
| Other Non-Current Liabilities | 10 | 15 | 0 | 0 | 0 |
| TOTAL | $132 | $137 | $122 | $122 | $N/A |
| Total Liabilities | $12,073 | $11,531 | $11,221 | $10,216 | $9,327 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 894 | 872 | 853 | 847 | 847 |
| Common Shares | 421 | 5 | 407 | 407 | 404 |
| Retained earnings | -101,283 | -99,064 | -97,171 | -93,668 | -92,501 |
| TOTAL | $-11,424 | $-11,311 | $-11,091 | $-9,993 | $-9,148 |
| Total Liabilities And Equity | $649 | $220 | $130 | $223 | $179 |